Atlas Venture Life Science Advisors as of Sept. 30, 2025
Portfolio Holdings for Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors holds 9 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kymera Therapeutics Common Stock (KYMR) | 36.8 | $277M | 4.9M | 56.60 | |
| Disc Medicine Common Stock (IRON) | 18.8 | $142M | 2.1M | 66.08 | |
| Dyne Therapeutics Common Stock (DYN) | 15.3 | $116M | 9.1M | 12.65 | |
| Sionna Therapeutics Common Stock (SION) | 14.1 | $106M | 3.6M | 29.41 | |
| Korro Bio Common Stock (KRRO) | 7.2 | $55M | 1.1M | 47.89 | |
| Day One Biopharmaceuticals Common Stock (DAWN) | 6.0 | $45M | 6.4M | 7.05 | |
| Generation Bio Common Stock | 0.7 | $5.1M | 828k | 6.12 | |
| Q32 Bio Common Stock (QTTB) | 0.6 | $4.1M | 2.1M | 1.98 | |
| ImageneBio Common Stock | 0.4 | $3.1M | 378k | 8.15 |
